| 1:21-cv-00314 | Bayer Pharma AG et al v. Lupin Limited et al | Mar 1, 2021 |
| 1:21-cv-00566 | Bayer Pharma AG et al v. Accord Healthcare Inc. et al | Apr 22, 2021 |
| 1:21-cv-00732 | Bayer Pharma AG et al v. Dr. Reddys Laboratories, Ltd. et al | May 24, 2021 |
| 1:21-cv-01000 | Bayer Pharma AG et al v. Taro Pharmaceutical Industries Ltd. et al | Jul 7, 2021 |
| 1:21-cv-01001 | Bayer Pharma AG et al v. Teva Pharmaceuticals USA, Inc. | Jul 7, 2021 |
| 1:21-cv-00099 | Bayer Pharma AG et al v. Mylan Pharmaceuticals Inc. et al | Jul 22, 2021 |
| 1:21-cv-01742 | Bayer Pharma AG et al v. Mylan Pharmaceuticals Inc. et al | Dec 10, 2021 |
| IPR2022-00517 | Mylan Pharmaceuticals Inc. et al. v. Bayer Pharma AG et al. | Feb 2, 2022 |
| 1:22-cv-00165 | Bayer Pharma AG et al v. Micro Labs Ltd. et al | Feb 4, 2022 |
| 1:22-cv-00063 | Bayer Pharma AG, et al v. Mylan Pharmaceuticals Inc. et al | Aug 5, 2022 |
| IPR2022-01515 | InvaGen Pharmaceuticals, Inc. et al. v. Bayer Pharma AG et al. | Sep 8, 2022 |
| 3:22-cv-05485 | BAYER INTELLECTUAL PROPERTY GMBH et al v. USV PRIVATE LIMITED | Sep 9, 2022 |
| IPR2022-01513 | Teva Pharmaceuticals USA, Inc v. Bayer Pharma AG et al. | Sep 9, 2022 |
| 2:22-cv-05485 | BAYER INTELLECTUAL PROPERTY GMBH et al v. USV PRIVATE LIMITED | Sep 9, 2022 |
| 1:22-cv-01228 | Bayer Pharma AG, et al v. Mylan Pharmaceuticals Inc. et al | Sep 21, 2022 |
| 1:22-cv-01481 | Bayer Intellectual Property GMBH et al v. Epic Pharma, LLC | Nov 10, 2022 |
| 1:22-cv-01492 | Bayer Intellectual Property GMBH et al v. USV Private Limited | Nov 14, 2022 |
| 1:22-cv-01596 | Bayer Pharma AG et al v. Apotex Inc. et al | Dec 14, 2022 |
| 2:23-cv-00018 | JAZZ PHARMACEUTICALS RESEARCH UK LIMITED v. TEVA PHARMACEUTICALS, INC. et al | Jan 3, 2023 |
| 1:23-cv-00256 | GW Research Limited v. InvaGen Pharmaceuticals, Inc. et al | Jan 13, 2023 |
| 1:23-cv-00335 | Bayer Intellectual Property GMBH et al v. ScieGen Pharmaceuticals, Inc. | Mar 24, 2023 |
| 1:23-cv-00334 | Bayer Intellectual Property GmbH et al v. Biocon Pharma Limited et al | Mar 24, 2023 |
| 1:23-cv-00551 | Bayer Pharma AG et al v. Teva Pharmaceuticals USA, Inc. | May 19, 2023 |
| 2:23-cv-03020 | BAYER INTELLECTUAL PROPERTY GMBH et al v. AUSON PHARMACEUTICALS INC. et al | Jun 1, 2023 |
| 1:23-cv-00665 | Bayer Pharma AG et al v. Macleods Pharmaceuticals Ltd. et al | Jun 16, 2023 |
| 1:23-cv-00690 | Bayer Intellectual Property GmbH et al v. Indoco Remedies Limited et al | Jun 23, 2023 |
| 1:23-cv-01103 | Bayer Intellectual Property Gmbh, et al. v. Auson Pharmaceuticals Inc., et al. | Oct 5, 2023 |
| 1:23-cv-01196 | Bayer Pharma AG et al v. Cipla Ltd. et al | Oct 20, 2023 |
| 1:23-cv-01219 | Bayer Pharma AG et al v. Taro Pharmaceutical Industries Ltd. et al | Oct 26, 2023 |
| 1:23-cv-01372 | Bayer Pharma AG et al v. Aurobindo Pharma Limited et al | Dec 1, 2023 |
| 1:23-cv-01383 | AstraZeneca AB v. Sun Pharmaceutical Industries Limited et al | Dec 4, 2023 |
| 1:23-cv-01456 | Bayer Intellectual Property GMBH et al v. Umedica Laboratories Pvt. Ltd. | Dec 21, 2023 |
| 1:24-cv-00138 | Bayer Pharma AG et al v. Lupin Limited et al | Feb 2, 2024 |
| 1:24-cv-00336 | Bayer Intellectual Property GmbH et al v. Prinston Pharmaceutical, Inc. | Mar 14, 2024 |
| 1:24-cv-00336 | Factor2 Multimedia Systems, LLC v. Amazon.Com, Inc. | Mar 29, 2024 |
| 1:24-cv-00588 | Bayer Intellectual Property GMBH et al v. Ascent Pharmaceuticals Inc. et al | May 16, 2024 |
